Category: Pharmaceuticals
Global Pharmaceuticals
-
Polyphenols
... 7.2% over the analysis period 2024-2030. Functional Beverages Application, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$855.9 Million by the end of the analysis period. ... Read More
-
Automotive Closure
... CAGR of 6.7% over the analysis period 2024-2030. Light-Duty Vehicles, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$23.3 Billion by the end of the analysis ... Read More
-
Security and Law Enforcement Robots
... Billion by 2030, growing at a CAGR of 13.0% over the analysis period 2024-2030. Unmanned Logistics Application, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$5.5 ... Read More
-
Smart Pills
... CAGR of 11.6% over the analysis period 2024-2030. Esophagus Target Area, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$238.4 Million by the end of the ... Read More
-
qPCR Reagents
... CAGR of 7.4% over the analysis period 2024-2030. Dye-Based qPCR Reagents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Sexual Enhancers
... CAGR of 7.7% over the analysis period 2024-2030. Male Sexual Enhancers, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$354.9 Million by the end of the ... Read More
-
Intrathecal Pumps
... CAGR of 5.1% over the analysis period 2024-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the analysis period. ... Read More
-
In-Vitro Fertilization
... CAGR of 8.0% over the analysis period 2024-2030. In-Vitro Fertilization Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the ... Read More
-
Livestock Monitoring
... CAGR of 9.5% over the analysis period 2024-2030. Livestock Monitoring Hardware, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Sperm Banks
... CAGR of 5.3% over the analysis period 2024-2030. Sperm Storage Service, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Statins
... 1.8% over the analysis period 2024-2030. Synthetic Statins, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$12.2 Billion by the end of the analysis period. Growth ... Read More
-
Spine Biologics
... CAGR of 4.4% over the analysis period 2024-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More
-
Sterility Testing
... CAGR of 10.9% over the analysis period 2024-2030. Sterility Testing Kits & Reagents, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$184.9 Million by the end ... Read More
-
Superdisintegrants
... 5.4% over the analysis period 2024-2030. Synthetic Superdisintegrants, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$262.2 Million by the end of the analysis period. Growth ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Alopecia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis ... Read More
-
Aseptic Sampling
... CAGR of 10.1% over the analysis period 2024-2030. Manual Aseptic Sampling, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$357.4 Million by the end of the ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Automotive Paints
... CAGR of 2.6% over the analysis period 2024-2030. Clearcoat, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Brewing Enzymes
... CAGR of 5.7% over the analysis period 2024-2030. Amylase, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$271.7 Million by the end of the analysis period. ... Read More
-
Burn Care
... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
-
Veterinary Vaccines
... CAGR of 5.6% over the analysis period 2024-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$4.7 Billion by the end of the analysis ... Read More
-
Human Vaccines
... CAGR of 7.3% over the analysis period 2024-2030. Intramuscular & Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$58.7 Billion by the end of ... Read More
Research Assistance
